ÂÜÀòÂÒÂ×

Dr. Sally Ann Forsyth OBE is an accomplished leader in the life sciences sector, currently serving as Chief Executive Officer at Stevenage Bioscience Catalyst since March 2018, where the focus is on fostering a supportive environment for biotech, pharma, and med-tech businesses. In addition, Dr. Forsyth holds the position of Non Executive Director and Chair of the ESG Committee at Life Science REIT since November 2021. Previously, Dr. Forsyth was Chief Executive Officer at Norwich Research Park, leading its strategic growth and development from September 2013 to March 2018. With a background that includes roles as Director of Science Parks at Goodman International and Director of Colworth Science Park at Unilever, Dr. Forsyth has extensive experience in strategic development and innovation in the life sciences field. Educational qualifications include a PhD in Molecular Biology from the University of Cambridge and an MPhil in Genetics and Molecular Biology.